Open Access
Numéro
OCL
Volume 18, Numéro 4, Juillet-Août 2011
Lipids and Brain II. Actes des Journées Chevreul 2011 (Première partie)
Page(s) 228 - 235
Section Thesis Award
DOI https://doi.org/10.1051/ocl.2011.0397
Publié en ligne 15 juillet 2011
  • American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (IV). Washington DC, American Psychiatric Press, 1994. [Google Scholar]
  • American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (IV-TR). 4th Text Revised. Washington DC, American Psychiatric Press, 2000. [Google Scholar]
  • Amieva H, Le Goff M, et al. Prodromal Alzheimer’s disease: successive emergence of the clinical symptoms. Ann Neurol 2008; 64: 492–498. [CrossRef] [PubMed] [Google Scholar]
  • Brayne C. The elephant in the room - healthy brains in later life, epidemiology and public health. Nat Rev Neurosci 2007; 8: 233–239. [CrossRef] [PubMed] [Google Scholar]
  • Cunnane SC, Plourde M, et al. Fish, docosahexaenoic acid and Alzheimer’s disease. Prog Lipid Res 2009; 48: 239–256. [CrossRef] [PubMed] [Google Scholar]
  • Dubois B, Feldman HH, et al. Revising the definition of Alzheimer’s disease: a new lexicon. Lancet Neurol 2010; 9: 1118–1127. [CrossRef] [PubMed] [Google Scholar]
  • Dubois B, Feldman HH, et al. Research criteria for the diagnosis of Alzheimer’s disease: revising the NINCDS-ADRDA criteria. Lancet Neurol 2007; 6: 734–746. [CrossRef] [PubMed] [Google Scholar]
  • Farrer LA, Cupples LA, et al. Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium. Jama 1997; 278: 1349–1356. [CrossRef] [PubMed] [Google Scholar]
  • Feart C, Peuchant E, et al. Plasma eicosapentaenoic acid is inversely associated with severity of depressive symptomatology in the elderly: data from the Bordeaux sample of the Three-City Study. Am J Clin Nutr 2008; 87: 1156–1162. [CrossRef] [PubMed] [Google Scholar]
  • Feart C, Samieri C, et al. Diet and Alzheimer’s disease: new evidence from epidemiological studies. In: New research on Nutrition in the prevention of Alzheimer’s disease. Ramassamy&Bastianetto, Research Signpost/Transworld Research Network, Trivandrum, 2010. [Google Scholar]
  • Feart C, Samieri C, et al. Adherence to a Mediterranean diet, cognitive decline, and risk of dementia. Jama 2009; 302: 638–648. [Google Scholar]
  • Feart C, Torres MJ, et al. Adherence to a Mediterranean diet and plasma fatty acids: data from the Bordeaux sample of the Three-City study. Br J Nutr 2011; 1–10. [Google Scholar]
  • Fotuhi M, Hachinski V, et al. Changing perspectives regarding late-life dementia. Nat Rev Neurol 2009; 5: 649–658. [CrossRef] [PubMed] [Google Scholar]
  • Freeman MP, Hibbeln JR, et al. Omega-3 fatty acids: evidence basis for treatment and future research in psychiatry. J Clin Psychiatry 2006; 67: 1954–1967. [CrossRef] [PubMed] [Google Scholar]
  • Freemantle E, Vandal M, et al. Omega-3 fatty acids, energy substrates, and brain function during aging. Prostaglandins Leukot Essent Fatty Acids 2006; 75: 213–220. [CrossRef] [PubMed] [Google Scholar]
  • Jack Jr CR, Knopman DS, et al. Hypothetical model of dynamic biomarkers of the Alzheimer’s pathological cascade. Lancet Neurol 2010; 9: 119–128. [CrossRef] [PubMed] [Google Scholar]
  • Lin PY, Huang SY, et al. A meta-analytic review of polyunsaturated fatty acid compositions in patients with depression. Biol Psychiatry 2010; 68: 140–147. [CrossRef] [PubMed] [Google Scholar]
  • Moeller SM, Reedy J, et al. Dietary patterns: challenges and opportunities in dietary patterns research an Experimental Biology workshop, April 1, 2006. J Am Diet Assoc 2007; 107: 1233–1239. [CrossRef] [PubMed] [Google Scholar]
  • Panza F, Frisardi V, et al. Late-life depression, mild cognitive impairment, and dementia: possible continuum? Am J Geriatr Psychiatry 2010; 18: 98–116. [CrossRef] [PubMed] [Google Scholar]
  • Prince M, Jackson JC. World Alzheimer Report. London, England: A. s. D. International, 2009. [Google Scholar]
  • Reiman EM, Chen K, et al. Functional brain abnormalities in young adults at genetic risk for late-onset Alzheimer’s dementia. Proc Natl Acad Sci U S A 2004; 101: 284–289. [CrossRef] [PubMed] [Google Scholar]
  • Reitz C, Brayne C, et al. Epidemiology of Alzheimer disease. Nat Rev Neurol 2011; 7: 137–152. [CrossRef] [PubMed] [Google Scholar]
  • Samieri C, Feart C, et al. Low plasma eicosapentaenoic acid and depressive symptomatology are independant predictors of dementia risk. Am J Clin Nutr 2008; 88: 714–721. [PubMed] [Google Scholar]
  • Samieri C, Feart C, et al. Omega-3 fatty acids and cognitive decline: modulation by ApoEepsilon4 allele and depression. Neurobiol Aging 2010. In press. doi:10.1016/j.neurobiolaging.2010.03.020. [Google Scholar]
  • Samieri C, Jutand MA, et al. Dietary patterns derived by hybrid clustering method in older people: association with cognition, mood, and self-rated health. J Am Diet Assoc 2008; 108: 1461–1471. [CrossRef] [PubMed] [Google Scholar]
  • Sleegers K, Lambert JC, et al. The pursuit of susceptibility genes for Alzheimer’s disease: progress and prospects. Trends Genet 2010; 26: 84–93. [CrossRef] [PubMed] [Google Scholar]
  • Sofi F, Abbate R, et al. Accruing evidence about benefits of adherence to the Mediterranean diet on health: an updated systematic review and meta-analysis. Am J Clin Nutr 2010; 92: 1189–1196. [CrossRef] [PubMed] [Google Scholar]
  • Three-City study group. Vascular Risk factors and risk of dementia: design of the Three-City Study and baseline characteristics of the study population. Neuroepidemiology 2003; 22: 316–325. [CrossRef] [PubMed] [Google Scholar]
  • Trichopoulou A, Kouris-Blazos A, et al. Diet and overall survival in elderly people. BMJ 1995; 311: 1457–1460. [CrossRef] [PubMed] [Google Scholar]

Les statistiques affichées correspondent au cumul d'une part des vues des résumés de l'article et d'autre part des vues et téléchargements de l'article plein-texte (PDF, Full-HTML, ePub... selon les formats disponibles) sur la platefome Vision4Press.

Les statistiques sont disponibles avec un délai de 48 à 96 heures et sont mises à jour quotidiennement en semaine.

Le chargement des statistiques peut être long.